|
Product Name: | MGV354 | Synonyms: | MGV354;(Rac)-MGV354;pressure,drop,intraocular,Guanylate Cyclase,(Rac)MGV354,Inhibitor,activator,topical,(Rac) MGV354,inhibit,sGC,(Rac)-MGV354,(Rac)-MGV-354,ocular;MGV354|MGV 354 | CAS: | 1852495-86-3 | MF: | C35H37N5O3 | MW: | 575.71 | EINECS: | | Product Categories: | | Mol File: | 1852495-86-3.mol | ![MGV354 Structure](CAS/20211123/GIF/1852495-86-3.gif) |
| MGV354 Chemical Properties |
Boiling point | 824.8±65.0 °C(Predicted) | density | 1.36±0.1 g/cm3(Predicted) | solubility | DMSO : 100 mg/mL (173.70 mM; Need ultrasonic) | pka | 3.20±0.25(Predicted) | form | Solid | color | White to off-white |
| MGV354 Usage And Synthesis |
Biological Activity | (Rac)-MGV354 is the racemate of MGV354. MGV354 is a soluble guanylate cyclase (sGC) activator with EC50s of <0.5 nM, and 5 nM in CHO and GTM-3 E cells, respectively[1]. | References | [1]. Ehara T, et al. The Discovery of ( S)-1-(6-(3-((4-(1-(Cyclopropanecarbonyl)piperidin-4-yl)-2-methylphenyl)amino)-2,3-dihydro-1 H-inden-4-yl)pyridin-2-yl)-5-methyl-1 H-pyrazole-4-carboxylic Acid, a Soluble Guanylate Cyclase Activator Specifically Designed for Topical Ocular Delivery as a Therapy for Glaucoma. J Med Chem. 2018 Mar 22;61(6):2552-2570. |
| MGV354 Preparation Products And Raw materials |
|